Atlas Trials

Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B

Clinical trial NCT01369212 · COMPLETED

Trial details

NCT number
NCT01369212
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2012-11-01
Primary completion
2021-03-08
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.